Tamoxifen
Tamoxifen

1
A generic medicine indicated for women's health. Blocks specific hormone receptors on cells to address irregular cellular growth patterns in sensitive tissue areas.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Tamoxifen
Reference Brand
Nolvadex
Product Origin
Generic Product
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones, Oncology Support
Product Category
Selective Estrogen Receptor Modulator (SERM)
Pharmacological Class
Antineoplastic
Clinical Indications
Manufacturer Description
Formulated to alleviate estrogen-responsive tumor growth to support breast cancer remission and target cancer cells.
Mechanism of Action
Competitively blocks estrogen receptors in breast tumor tissues, preventing cell transcription and tumor proliferation.
Route of Administration
Oral
Onset Time
4–8 weeks
Duration
24 hours
Contraindications
Pregnancy, History of deep vein thrombosis, Concurrent coumarin anticoagulants
Severe Adverse Events
Venous thromboembolism — requires immediate medical attention, Endometrial cancer — requires immediate medical attention
Common Side Effects
Hot flashes, Nausea, Fatigue
Uncommon Side Effects
Vaginal discharge, Fluid retention, Menstrual irregularities
Drug Interactions
Warfarin, Rifampin, Paroxetine
Pregnancy Safety Warnings
TGA Category D: Highly teratogenic. Do not use in pregnancy. Breastfeeding: Contraindicated.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Tamoxifen is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to purchase Menopause Treatment Australia - Conjugated Estrogens HRT Oestrogen Tablet